134 related articles for article (PubMed ID: 6461438)
1. A sensitive colorimetric assay for thrombin, prothrombin and antithrombin III in human plasma using a new synthetic substrate.
Hitomi Y; Kanda T; Niinobe M; Fujii S
Clin Chim Acta; 1982 Mar; 119(3):157-64. PubMed ID: 6461438
[TBL] [Abstract][Full Text] [Related]
2. A sensitive colorimetric assay for human urinary kallikrein.
Hitomi Y; Niinobe M; Fujii S
Clin Chim Acta; 1980 Jan; 100(3):275-83. PubMed ID: 6986217
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates.
Morita T; Iwanaga S; Suzuki T
J Biochem; 1976 May; 79(5):1089-108. PubMed ID: 956136
[TBL] [Abstract][Full Text] [Related]
4. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
Asai K; Asai M
Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptide substrate assays for hemostasis testing.
Zolton RP
Adv Clin Chem; 1986; 25():117-68. PubMed ID: 2940818
[No Abstract] [Full Text] [Related]
7. Serine protease specificity for peptide chromogenic substrates.
Mattler LE; Bang NU
Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
[TBL] [Abstract][Full Text] [Related]
9. A microtitre plate ELISA to measure thrombin-antithrombin complex using pan-specific antibodies.
Boisclair MD; Lane DA
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):795-802. PubMed ID: 1489901
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
Ofosu FA; Fareed J; Smith LM; Anvari N; Hoppensteadt D; Blajchman MA
Eur J Biochem; 1992 Jan; 203(1-2):121-5. PubMed ID: 1730217
[TBL] [Abstract][Full Text] [Related]
12. New synthetic substrate for kallikrein and its application.
Fujii S; Hitomi Y; Kimura K; Ishii M; Kurumi M; Aoyama T
Adv Exp Med Biol; 1986; 198 Pt A():299-308. PubMed ID: 2949541
[TBL] [Abstract][Full Text] [Related]
13. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin-III assay without influence of heparin cofactor II.
Enomoto M; Tanimizu I; Sakuragawa N
Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin III: a backward glance o'er travel'd roads.
Seegers WH
Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
[TBL] [Abstract][Full Text] [Related]
17. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
18. [Thrombin markers in pregnant women: measurements of prothrombin fragments F 1+2 and thrombin-antithrombin III complexes (TAT) in the cord blood, the mother's blood and in amniotic fluid].
Uszyński W; Uszyński M; Zekanowska E
Ginekol Pol; 2004 Aug; 75(8):595-602. PubMed ID: 15517782
[TBL] [Abstract][Full Text] [Related]
19. A rapid and highly sensitive chromogenic microplate assay for quantification of rat and human prothrombin.
Rob JA; Tollefsen S; Helgeland L
Anal Biochem; 1997 Feb; 245(2):222-5. PubMed ID: 9056216
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
